2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol

Catalog No. :
ACFDAG305
CAS No. :
1355955-95-1
Molecular Formula :
C12H25ClO4
Molecular Weight :
268.78

IUPAC Name:2-(2-(2-((6-chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol

2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$84.00Login to see priceIn stockInquiry
100mg95%$136.00Login to see priceIn stockIn stock
250mg95%$272.00Login to see priceIn stockIn stock
1g95%$817.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol
IUPAC Name2-(2-(2-((6-chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol
MDL No.MFCD32705069
Molecular FormulaC12H25ClO4
Molecular Weight268.78
SMILESOCCOCCOCCOCCCCCCCl
InChI KeyDCDZHDUAQJDOIH-UHFFFAOYSA-N
SynonymEthanol, 2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]-;2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethan-1-ol;HO-PEG3-(CH2)6-Cl;HO-PEG3-(CH2)6-Cl/Ethanol, 2-[2-[2-[(6-chlorohexyl)oxy]ethoxy]ethoxy]-;2-[2-[2-[(6-Chlorohexyl)oxy]ethoxy]ethoxy]ethanol
CAS No.1355955-95-1

Safety Data

Pictogram
CorrosiveEnvironmental hazardHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H318-H411
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACFDAG305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMUBE124 route compound structure diagram
    ACMUBE1246294-17-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDAG305 route product structure diagram
    ACFDAG3051355955-95-1 In Stock
Inquiry

2. ACFDAG305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFDAG305 route product structure diagram
    ACFDAG3051355955-95-1 In Stock
Inquiry

Comments (0)